Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced several critical developments spanning food safety, medical device oversight, and healthcare innovation. These updates reflect the agency’s ongoing …
Your Health at Stake: FDA Sounds the Alarm on Tainted Oysters, Shocking PFAS Packaging Risks, and Bold Medical Breakthroughs! Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration isn’t just making a suggestion—it’s drawing a line in the sand. Last week, the FDA proposed a hard-hitting rule to establish standardized …
FDA Takes Bold Stand to Protect Consumers with Standardized Asbestos Testing in Talc-Based Cosmetics Read More
WASHINGTON, D.C. — The fight against type 2 diabetes just reached a groundbreaking milestone. Last week, the U.S. Food and Drug Administration (FDA) approved the first generic version of liraglutide injection, …
FDA Approves First Generic Liraglutide Injection, Ushering in a New Era for Type 2 Diabetes Treatment Read More
WASHINGTON, D.C. — The U.S. Department of Agriculture‘s (USDA) Food Safety and Inspection Service (FSIS) has just issued a national call to action. The hunt is on for experts, innovators, and …
USDA Seeks Top Minds to Revolutionize Food Safety—Step Up to Protect America’s Families Read More
WASHINGTON, D.C. — A seismic shift in pediatric medical care has arrived with the FDA’s approval of Ryoncil (remestemcel-L-rknd), a revolutionary therapy aimed at tackling the devastating condition known as steroid-refractory …
FDA Approves Groundbreaking Cell Therapy for Life-Threatening Pediatric Disease Read More
WASHINGTON, D.C. — The fight against obstructive sleep apnea (OSA) has taken a monumental leap forward. For the first time, the U.S. Food and Drug Administration (FDA) has approved a drug …
FDA Approves Zepbound in Landmark Move to Battle Obstructive Sleep Apnea Read More
WASHINGTON, D.C. — A breakthrough in life-saving medical technology has arrived. The U.S. Food and Drug Administration (FDA) has officially approved Symvess, the first acellular tissue-engineered vessel designed to repair damaged …
FDA Approves First-Ever Tissue-Engineered Vessel for Vascular Trauma Read More
WASHINGTON, D.C. — Nutrition just got a major overhaul, and it’s long overdue. The U.S. Food and Drug Administration (FDA) has announced a new, stricter definition for the term “healthy” as …
FDA Redefines ‘Healthy’ to Combat America’s Diet-Related Health Crisis Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has initiated the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI, a potential …
Savara Begins FDA Submission for Rare Lung Disease Treatment Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use alongside glucocorticoids in managing classic congenital adrenal hyperplasia (CAH) in patients aged four and older. …
FDA Approves Crenessity for Treating Classic Congenital Adrenal Hyperplasia Read More